Paradoxical worsening of tuberculosis in a heart-lung transplant recipient

Transplant Infectious Disease

Volumn 9, Issue 3, 2007, Pages 219-224

  Place, S ^a   Knoop, C ^a   Remmelink, M ^a   Baldassarre, S ^a   Van Vooren, J P ^a   Jacobs, F ^a   Mascart, F ^a   Estenne, M ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Lung transplantation; Paradoxical response; Tuberculosis

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; STEROID; THYMOCYTE ANTIBODY; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TUBERCULOSIS; MYCOSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTRICTIVE CARDIOMYOPATHY; SINGLE DRUG DOSE;

ADULT; BRONCHOALVEOLAR LAVAGE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; MALE; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 34547799629     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00194.x     Document Type: Article

References (20)

1. Cheng VCC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected-patients. Eur J Clin Microbiol Infect Dis 2002 21: 803 809.
2. Breen RAM, Smith CJ, Bettinson H, et al. Paradoxical reaction during tuberculosis treatment in patient with and without HIV co-infection. Thorax 2004 59: 704 707.
3. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998 158: 157 161.
4. Asano T, Kawamoyto H, Asamuka J, Tanimoto T, Kobayashi H, Hayakawa M. Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient. Transplant Proc 2000 32: 1960 1962.
5. Burman WJ, Reves RR. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 2000 31: 1390 1395.
6. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998 27: 1266 1277.
7. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002 17: 274 283.
8. Winthrop KL, Kubak BM, Pegues DA, et al. Transmission of Mycobacterium tuberculosis via lung transplantation. Am J Transplant 2004 4: 1529 1533.
9. Lee J, Yew WW, Wong CF, Wong PC, Chiu CS. Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant 2002 22: 1168 1173.
10. Bravo C, Roldan J, Roman A, et al. Tuberculosis in lung transplant recipients. Transplantation 2005 79: 59 64.
11. Roman A, Bravo C, Levy G, et al. Isoniazid prophylaxis in lung transplantation. J Heart Lung Transplant 2000 19: 903 906.
12. Condos R, Rom WN, Liu YM, Schluger NW. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 1998 157: 729 735.
13. Tsao TC, Chen CH, Hong JH, Hsieh MJ, Tsao KC, Lee CH. Shifts of T4/T8T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest 2002 122: 1285 1291.
14. Urdaneta E, Feo-Figarella E, Montalvo C, et al. Characterization of local memory cells in stage-classified pulmonary tuberculosis: preliminary observations. Scand J Immunol 1998 47: 496 501.
15. Slebos DJ, Scholma J, Boezen HM, et al. Longitudinal profile of bronchoalveolar lavage cell characteristics in patients with good outcome after lung transplantation. Am J Respir Crit Care Med 2002 165: 501 507.
16. Raja A. Immunology of tuberculosis. Indian J Med Res 2004 120: 213 232.
17. Vankayalapati R, Klucar P, Wizel B, et al. NK cells regulate CD8+T cell effector function in response to an intracellular pathogen. J Immunol 2004 172: 130 137.
18. De La Barrera SS, Finiasz M, Frias A, et al. Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis. Clin Exp Immunol 2003 132: 450 461.
19. Barry SM, Lipman MC, Bannister B, Johnson MA, Janossy G. Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and non-pulmonary tuberculosis. J Infect Dis 2003 187: 243 250.
20. Vilcek J, Klion A, Henriksen-DeStefano D, et al. Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 1986 6: 146 152.